MD Annual EBITDA
$29.89 M
-$126.81 M-80.93%
31 December 2023
Summary:
As of January 19, 2025, MD annual earnings before interest, taxes, depreciation & amortization is $29.89 million, with the most recent change of -$126.81 million (-80.93%) on December 31, 2023. During the last 3 years, it has fallen by -$116.18 million (-79.54%). MD annual EBITDA is now -95.51% below its all-time high of $666.15 million, reached on December 31, 2016.MD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MD Quarterly EBITDA
$41.62 M
+$190.24 M+128.00%
30 September 2024
Summary:
As of January 19, 2025, MD quarterly earnings before interest, taxes, depreciation & amortization is $41.62 million, with the most recent change of +$190.24 million (+128.00%) on September 30, 2024. Over the past year, it has dropped by -$8.80 million (-17.46%). MD quarterly EBITDA is now -77.15% below its all-time high of $182.09 million, reached on September 30, 2016.MD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MD TTM EBITDA
-$197.99 M
-$8.80 M-4.65%
30 September 2024
Summary:
As of January 19, 2025, MD TTM earnings before interest, taxes, depreciation & amortization is -$197.99 million, with the most recent change of -$8.80 million (-4.65%) on September 30, 2024. Over the past year, it has dropped by -$394.50 million (-200.76%). MD TTM EBITDA is now -129.68% below its all-time high of $667.18 million, reached on September 30, 2016.MD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.9% | -17.5% | -200.8% |
| 3 y3 years | -79.5% | -17.5% | -200.8% |
| 5 y5 years | -89.5% | -17.5% | -200.8% |
MD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.3% | at low | -46.6% | +128.0% | -183.9% | at low |
| 5 y | 5-year | -87.3% | at low | -46.6% | +128.0% | -170.0% | at low |
| alltime | all time | -95.5% | +221.4% | -77.2% | +116.4% | -129.7% | at low |
Pediatrix Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $41.62 M(-128.0%) | -$197.99 M(+4.7%) |
| June 2024 | - | -$148.63 M(-617.3%) | -$189.19 M(-1119.2%) |
| Mar 2024 | - | $28.73 M(-124.0%) | $18.56 M(-37.9%) |
| Dec 2023 | $29.89 M(-80.9%) | -$119.71 M(-337.4%) | $29.89 M(-84.8%) |
| Sept 2023 | - | $50.42 M(-14.7%) | $196.51 M(-3.4%) |
| June 2023 | - | $59.12 M(+47.6%) | $203.42 M(-0.5%) |
| Mar 2023 | - | $40.05 M(-14.6%) | $204.51 M(+30.5%) |
| Dec 2022 | $156.70 M(-33.6%) | $46.91 M(-18.2%) | $156.70 M(-16.5%) |
| Sept 2022 | - | $57.33 M(-4.8%) | $187.77 M(-5.9%) |
| June 2022 | - | $60.22 M(-876.1%) | $199.62 M(-1.3%) |
| Mar 2022 | - | -$7.76 M(-110.0%) | $202.27 M(-14.3%) |
| Dec 2021 | $236.10 M(+61.6%) | $77.98 M(+12.7%) | $236.10 M(+16.0%) |
| Sept 2021 | - | $69.18 M(+10.0%) | $203.47 M(+17.8%) |
| June 2021 | - | $62.88 M(+141.2%) | $172.76 M(+11.4%) |
| Mar 2021 | - | $26.07 M(-42.5%) | $155.08 M(+6.2%) |
| Dec 2020 | $146.07 M(-28.3%) | $45.35 M(+17.9%) | $146.07 M(-2.2%) |
| Sept 2020 | - | $38.47 M(-14.9%) | $149.39 M(-10.8%) |
| June 2020 | - | $45.20 M(+165.0%) | $167.49 M(-15.7%) |
| Mar 2020 | - | $17.05 M(-65.0%) | $198.66 M(-29.8%) |
| Dec 2019 | $203.64 M(-28.2%) | $48.67 M(-14.0%) | $282.98 M(+135.1%) |
| Sept 2019 | - | $56.56 M(-25.9%) | $120.38 M(-37.8%) |
| June 2019 | - | $76.38 M(-24.7%) | $193.52 M(-26.2%) |
| Mar 2019 | - | $101.37 M(-189.0%) | $262.31 M(-7.5%) |
| Dec 2018 | $283.51 M(-47.4%) | -$113.93 M(-187.8%) | $283.51 M(-43.7%) |
| Sept 2018 | - | $129.71 M(-10.6%) | $503.27 M(-4.2%) |
| June 2018 | - | $145.16 M(+18.4%) | $525.10 M(-0.7%) |
| Mar 2018 | - | $122.58 M(+15.8%) | $528.64 M(-1.9%) |
| Dec 2017 | $539.09 M(-19.1%) | $105.83 M(-30.2%) | $539.09 M(-10.6%) |
| Sept 2017 | - | $151.54 M(+1.9%) | $602.87 M(-4.8%) |
| June 2017 | - | $148.69 M(+11.8%) | $633.42 M(-3.1%) |
| Mar 2017 | - | $133.02 M(-21.6%) | $653.95 M(-1.8%) |
| Dec 2016 | $666.15 M(+6.2%) | $169.61 M(-6.9%) | $666.15 M(-0.2%) |
| Sept 2016 | - | $182.09 M(+7.6%) | $667.18 M(+1.9%) |
| June 2016 | - | $169.22 M(+16.5%) | $654.49 M(+1.8%) |
| Mar 2016 | - | $145.23 M(-14.9%) | $642.90 M(+2.5%) |
| Dec 2015 | $627.07 M(+11.3%) | $170.64 M(+0.7%) | $627.07 M(+2.4%) |
| Sept 2015 | - | $169.40 M(+7.5%) | $612.52 M(+3.1%) |
| June 2015 | - | $157.63 M(+21.8%) | $593.91 M(+3.0%) |
| Mar 2015 | - | $129.40 M(-17.1%) | $576.79 M(+2.4%) |
| Dec 2014 | $563.50 M(+14.1%) | $156.09 M(+3.5%) | $563.50 M(+3.9%) |
| Sept 2014 | - | $150.79 M(+7.3%) | $542.34 M(+3.2%) |
| June 2014 | - | $140.52 M(+21.0%) | $525.68 M(+3.3%) |
| Mar 2014 | - | $116.10 M(-14.0%) | $508.80 M(+3.0%) |
| Dec 2013 | $493.79 M(+16.9%) | $134.93 M(+0.6%) | $493.79 M(+4.9%) |
| Sept 2013 | - | $134.12 M(+8.5%) | $470.65 M(+4.1%) |
| June 2013 | - | $123.64 M(+22.3%) | $452.25 M(+3.6%) |
| Mar 2013 | - | $101.10 M(-9.6%) | $436.40 M(+3.4%) |
| Dec 2012 | $422.23 M(+10.5%) | $111.80 M(-3.4%) | $422.23 M(+3.1%) |
| Sept 2012 | - | $115.72 M(+7.4%) | $409.72 M(+3.6%) |
| June 2012 | - | $107.79 M(+24.0%) | $395.58 M(+2.1%) |
| Mar 2012 | - | $86.93 M(-12.4%) | $387.28 M(+1.3%) |
| Dec 2011 | $382.18 M(+13.6%) | $99.28 M(-2.3%) | $382.18 M(+1.9%) |
| Sept 2011 | - | $101.59 M(+2.1%) | $374.95 M(+3.7%) |
| June 2011 | - | $99.48 M(+21.6%) | $361.50 M(+3.5%) |
| Mar 2011 | - | $81.83 M(-11.1%) | $349.39 M(+3.9%) |
| Dec 2010 | $336.30 M(+9.5%) | $92.06 M(+4.5%) | $336.30 M(+2.5%) |
| Sept 2010 | - | $88.13 M(+0.9%) | $328.15 M(+1.7%) |
| June 2010 | - | $87.37 M(+27.1%) | $322.74 M(+2.5%) |
| Mar 2010 | - | $68.73 M(-18.1%) | $314.77 M(+2.5%) |
| Dec 2009 | $307.06 M | $83.91 M(+1.4%) | $307.06 M(+3.9%) |
| Sept 2009 | - | $82.73 M(+4.2%) | $295.54 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $79.39 M(+30.1%) | $278.30 M(+5.0%) |
| Mar 2009 | - | $61.03 M(-15.7%) | $265.01 M(+2.4%) |
| Dec 2008 | $258.22 M(+8.4%) | $72.38 M(+10.5%) | $258.87 M(-0.7%) |
| Sept 2008 | - | $65.49 M(-0.9%) | $260.76 M(+0.4%) |
| June 2008 | - | $66.11 M(+20.5%) | $259.68 M(+2.6%) |
| Mar 2008 | - | $54.88 M(-26.1%) | $253.22 M(+6.3%) |
| Dec 2007 | $238.32 M(+16.9%) | $74.28 M(+15.3%) | $238.32 M(+11.8%) |
| Sept 2007 | - | $64.41 M(+8.0%) | $213.18 M(+2.7%) |
| June 2007 | - | $59.65 M(+49.2%) | $207.63 M(+1.8%) |
| Mar 2007 | - | $39.98 M(-18.7%) | $203.94 M(+0.0%) |
| Dec 2006 | $203.88 M(+33.4%) | $49.15 M(-16.5%) | $203.88 M(-305.4%) |
| Sept 2006 | - | $58.86 M(+5.2%) | -$99.28 M(-10.8%) |
| June 2006 | - | $55.96 M(+40.2%) | -$111.36 M(-8.2%) |
| Mar 2006 | - | $39.92 M(-115.7%) | -$121.25 M(-6.2%) |
| Dec 2005 | $152.79 M(-6.0%) | -$254.01 M(-643.0%) | -$129.20 M(-178.6%) |
| Sept 2005 | - | $46.78 M(+1.5%) | $164.38 M(+1.8%) |
| June 2005 | - | $46.06 M(+44.1%) | $161.45 M(+2.1%) |
| Mar 2005 | - | $31.97 M(-19.2%) | $158.13 M(-2.8%) |
| Dec 2004 | $162.60 M(+11.9%) | $39.57 M(-9.7%) | $162.60 M(-0.9%) |
| Sept 2004 | - | $43.84 M(+2.6%) | $164.08 M(+2.0%) |
| June 2004 | - | $42.74 M(+17.3%) | $160.93 M(+5.5%) |
| Mar 2004 | - | $36.44 M(-11.2%) | $152.52 M(+5.0%) |
| Dec 2003 | $145.29 M(+22.9%) | $41.05 M(+0.9%) | $145.29 M(+6.3%) |
| Sept 2003 | - | $40.70 M(+18.5%) | $136.63 M(+6.1%) |
| June 2003 | - | $34.33 M(+17.5%) | $128.72 M(+4.0%) |
| Mar 2003 | - | $29.22 M(-9.8%) | $123.74 M(+4.7%) |
| Dec 2002 | $118.21 M(+48.0%) | $32.39 M(-1.2%) | $118.21 M(+6.1%) |
| Sept 2002 | - | $32.79 M(+11.7%) | $111.45 M(+6.4%) |
| June 2002 | - | $29.35 M(+23.9%) | $104.76 M(+12.7%) |
| Mar 2002 | - | $23.69 M(-7.6%) | $92.98 M(+16.4%) |
| Dec 2001 | $79.88 M(+106.5%) | $25.63 M(-1.8%) | $79.88 M(+20.2%) |
| Sept 2001 | - | $26.09 M(+48.5%) | $66.43 M(+27.3%) |
| June 2001 | - | $17.57 M(+66.0%) | $52.19 M(+34.2%) |
| Mar 2001 | - | $10.58 M(-13.1%) | $38.88 M(+0.5%) |
| Dec 2000 | $38.68 M(-32.1%) | $12.18 M(+2.8%) | $38.68 M(-1.8%) |
| Sept 2000 | - | $11.85 M(+178.0%) | $39.40 M(-2.4%) |
| June 2000 | - | $4.26 M(-59.0%) | $40.35 M(-23.1%) |
| Mar 2000 | - | $10.38 M(-19.5%) | $52.45 M(-7.9%) |
| Dec 1999 | $57.00 M(-1.0%) | $12.90 M(+0.8%) | $56.97 M(-5.9%) |
| Sept 1999 | - | $12.80 M(-21.8%) | $60.57 M(-4.3%) |
| June 1999 | - | $16.37 M(+9.9%) | $63.27 M(+3.7%) |
| Mar 1999 | - | $14.90 M(-9.7%) | $61.00 M(+5.9%) |
| Dec 1998 | $57.60 M(+53.2%) | $16.50 M(+6.5%) | $57.60 M(+9.1%) |
| Sept 1998 | - | $15.50 M(+9.9%) | $52.80 M(+11.6%) |
| June 1998 | - | $14.10 M(+22.6%) | $47.30 M(+13.7%) |
| Mar 1998 | - | $11.50 M(-1.7%) | $41.60 M(+11.2%) |
| Dec 1997 | $37.60 M(+72.5%) | $11.70 M(+17.0%) | $37.40 M(+15.8%) |
| Sept 1997 | - | $10.00 M(+19.0%) | $32.30 M(+13.3%) |
| June 1997 | - | $8.40 M(+15.1%) | $28.50 M(+13.1%) |
| Mar 1997 | - | $7.30 M(+10.6%) | $25.20 M(+14.5%) |
| Dec 1996 | $21.80 M(+100.0%) | $6.60 M(+6.5%) | $22.00 M(+15.8%) |
| Sept 1996 | - | $6.20 M(+21.6%) | $19.00 M(+18.0%) |
| June 1996 | - | $5.10 M(+24.4%) | $16.10 M(-19.5%) |
| Mar 1996 | - | $4.10 M(+13.9%) | $20.00 M(-19.7%) |
| Dec 1995 | $10.90 M(+17.2%) | $3.60 M(+9.1%) | $24.90 M(+329.3%) |
| Sept 1995 | - | $3.30 M(-63.3%) | $5.80 M(-45.3%) |
| June 1995 | - | $9.00 M(0.0%) | $10.60 M(+9.3%) |
| Mar 1995 | - | $9.00 M(-158.1%) | $9.70 M(+10.2%) |
| Dec 1994 | $9.30 M | -$15.50 M(-291.4%) | $8.80 M(-63.8%) |
| Sept 1994 | - | $8.10 M(0.0%) | $24.30 M(+50.0%) |
| June 1994 | - | $8.10 M(0.0%) | $16.20 M(+100.0%) |
| Mar 1994 | - | $8.10 M | $8.10 M |
FAQ
- What is Pediatrix Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Pediatrix Medical?
- What is Pediatrix Medical annual EBITDA year-on-year change?
- What is Pediatrix Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Pediatrix Medical?
- What is Pediatrix Medical quarterly EBITDA year-on-year change?
- What is Pediatrix Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Pediatrix Medical?
- What is Pediatrix Medical TTM EBITDA year-on-year change?
What is Pediatrix Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MD is $29.89 M
What is the all time high annual EBITDA for Pediatrix Medical?
Pediatrix Medical all-time high annual earnings before interest, taxes, depreciation & amortization is $666.15 M
What is Pediatrix Medical annual EBITDA year-on-year change?
Over the past year, MD annual earnings before interest, taxes, depreciation & amortization has changed by -$126.81 M (-80.93%)
What is Pediatrix Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MD is $41.62 M
What is the all time high quarterly EBITDA for Pediatrix Medical?
Pediatrix Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is $182.09 M
What is Pediatrix Medical quarterly EBITDA year-on-year change?
Over the past year, MD quarterly earnings before interest, taxes, depreciation & amortization has changed by -$8.80 M (-17.46%)
What is Pediatrix Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MD is -$197.99 M
What is the all time high TTM EBITDA for Pediatrix Medical?
Pediatrix Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is $667.18 M
What is Pediatrix Medical TTM EBITDA year-on-year change?
Over the past year, MD TTM earnings before interest, taxes, depreciation & amortization has changed by -$394.50 M (-200.76%)